BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,332,000 | +21.0% | 48,503 | +16.6% | 5.92% | -15.4% |
| Q2 2022 | $6,062,000 | +1842.9% | 41,603 | +1480.1% | 7.00% | +2462.6% |
| Q1 2022 | $312,000 | -14.5% | 2,633 | -0.6% | 0.27% | +28.2% |
| Q4 2021 | $365,000 | +9.6% | 2,650 | +10.4% | 0.21% | -6.2% |
| Q3 2021 | $333,000 | +55.6% | 2,400 | +9.1% | 0.23% | +63.3% |
| Q2 2021 | $214,000 | -16.7% | 2,200 | -53.4% | 0.14% | -72.7% |
| Q4 2019 | $257,000 | -48.6% | 4,721 | -60.7% | 0.51% | -26.7% |
| Q3 2019 | $500,000 | -23.4% | 12,000 | -19.5% | 0.70% | -22.4% |
| Q2 2019 | $653,000 | – | 14,900 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |